Member Info for Daveavt

Pyc doesn't 'develop' cancer drugs. It just simulates the best amount to take and how often. Stig is Jack on here, the master ramper.

Ha, gutted.. how much loss you still sitting at?

I made 30 percent, clear, so I've missed out on an extra 15 percent, minus the spread? So 10 percent? How much did you buy in the 5s? ;) zilch....

I haven't missed out on 50 percent though have I?..

No I don't regret selling, because I made money...I know you're new to this radical concept. I know RRR, you tell me what your current break even price is and I'll make sure I'll buy in just below it just to p1ss you off ;)

Nope, 5p, hence why I've bought in a few times circa this price. So, how much have you made so far? or is it still a negative figure? Do you even have invested as much as I've made so far in profit?

Ha, let's add up everything you missed out on in the last 6 months. My rough tally up is about 8700 now, tell me again how much you've made so far? This is where you need to learn, this is a merry go round, you need to get on and off and often as possible. Not sit on it for 6 months with a dead butt...

Of course I sold. That's how you make money. Are you still sitting at a loss?

The widening of the spread is exactly what will bring it down.

No rns, but a ramp fest. 'This tech is worth millions'...no it isn't, it's worth 35 grand a pop.

No, you didn't get it wrong, no one knows what's around the corner, think of all the people that get it wrong every day sitting when they could have traded. If you're happy with the profit, then that's that. Trading opportunities out weigh spikes 1000 to 1.

..and as below, another person that thinks what they say will bring the price down, just by repeating the same thing over and over with no substance.

They probably said the same thing when they took on Black Cactus...

...yawn.

How many times, NOTHING you write on a forum is going to affect a share price. So why do people have this urge to write glowing biased cheer leading for their share as if some one is going to read it and think 'oh that sounds good, I'll buy some of this'. The guy below just admitted he is sitting at a loss, but had to turn up to say how 'amazing' this share is. Cringe worthy.

Unfortunately no, their tech is behind all the other companies doing similar things, what with expired patents, hence why the company has barely made more revenues than a local clothes shop in all it's years, and can only survive with the back up of grants. It has a very small amount of customers, and all customers would be 'big pharma' as that is who the product is designed for. But as I said I'd you buy in at this price, you can make some money, but as per usual, as you're already invested and sitting at a loss, you just tried to ramp it.

Year end results to June 2017 were only 130k revenues, from June to Dec 2017, it was only 79k revenue, so these clinical trials they were doing with Merck, which must have been in that year, were certainly no where near 100k each.

Would still like to see where clinical trials cost 100k as you stated, as pyc last financials certainly don't show revenues like that coming in.

Yes, that's Merck, who it's been working with since 2012, as they stated. 6 years until it got to them using pyc for clinical, and they have only estimated it will spend only 500k in a year. Proves the point I made.

Anyway, you have to value a company on what is happening, not 'hypothetically could'. Have you had any rns for '100k clinical trials'? . Nope.